Side-by-side comparison of AI visibility scores, market position, and capabilities
Tarrytown NY biopharma giant; creator of Dupixent (>$14B revenue), Eylea, and Kevzara. Velocity Genome platform drives fast antibody and bispecific drug discovery.
Regeneron Pharmaceuticals was founded in 1988 in Tarrytown, New York by Leonard Schleifer and George Yancopoulos. The company built its reputation on the Velocimmune platform—a proprietary humanized mouse technology that dramatically accelerates the discovery of human antibodies—and has used it to produce multiple best-in-class biologics across inflammatory, oncologic, and eye diseases.\n\nRegeneron's commercial portfolio is anchored by Dupixent (dupilumab), developed with Sanofi, which has become one of the best-selling drugs globally with over $14 billion in 2024 revenues, treating atopic dermatitis, asthma, COPD, and other type-2 inflammatory conditions. Additional key products include Eylea (aflibercept) for macular degeneration and PRALUENT for cardiovascular cholesterol lowering. The company's bispecific antibody pipeline, cancer vaccines in collaboration with BioNTech, and gene therapy programs represent its next growth wave.\n\nRegeneron reported over $14 billion in annual revenue in 2024 and maintains a world-class science culture, consistently ranking among the top companies for R&D productivity and employee satisfaction. Its Tarrytown campus houses more than 10,000 employees and remains a leading independent US biopharmaceutical innovator.
Tesla (TSLA) reported $97.7B revenue in FY2024, up 1% YoY. 1.8M vehicles delivered. Market cap ~$900B. 140,000+ employees. Austin, TX. FSD (Full Self-Driving), Optimus humanoid robot, Dojo AI training supercomputer.
Tesla is an electric vehicle and clean energy company founded in 2003 by Martin Eberhard and Marc Tarpenning in San Carlos, California, and subsequently co-founded and led by Elon Musk, who joined as chairman and lead investor in 2004. The company was built on the premise that electric vehicles could be desirable, high-performance automobiles — not compromise products — and that compelling EVs would accelerate the world's transition to sustainable energy. Musk's strategy, articulated in the 2006 "Secret Master Plan," was to start with a premium sports car (Roadster), use the proceeds to build a more affordable sedan (Model S), and ultimately produce a mass-market vehicle (Model 3). Tesla trades on Nasdaq under the ticker TSLA and has since expanded its mission to encompass solar energy, stationary storage, and autonomous driving.\n\nTesla's product portfolio spans the Model 3 (sedan), Model Y (compact SUV — the world's best-selling vehicle in 2023), Model S (premium sedan), Model X (premium SUV), Cybertruck (full-size electric pickup), and the Tesla Semi commercial truck. The company's energy business includes the Powerwall home battery, Megapack utility-scale storage, and Solar Roof installations. Tesla's Full Self-Driving (FSD) software suite provides driver assistance capabilities up to supervised autonomous driving, with a paid subscription and per-vehicle purchase option. Tesla operates a proprietary Supercharger network of 50,000+ charging stations globally, a significant infrastructure moat that has become accessible to competing EV brands through industry NACS adapter adoption.\n\nTesla reported FY2024 revenue of $97.7 billion, up approximately 1% year over year, with 1.8 million vehicles delivered and a market capitalization of approximately $900 billion — making it one of the ten most valuable companies in the world. The company employs 140,000+ people and operates Gigafactories in Austin (Texas), Fremont (California), Shanghai, Berlin, and Nevada. Despite increasing competition from BYD in China and European automakers globally, Tesla's vertical integration, software-defined vehicle architecture, FSD capability, and energy storage business position it as the defining company of the electric transportation and distributed energy era.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.